Found 8 articles for: "outcome"
Postoperative Complication Risks in Melanoma in situ Treated With Mohs Surgery or Wide Local Excision
September 2026 | Volume 25 | Issue 9 | Editorials | e87 | Copyright © September 2026
Report From the 2024 International Dermatology Outcome Measures (IDEOM) Annual Meeting
December 2025 | Volume 24 | Issue 12 | Original Article | 1215 | Copyright © December 2025
Background: International Dermatology Outcome Measures (IDEOM) is a nonprofit organization committed to advancing the development and accessibility of evidence-based, consensus-d...
Read MoreMohs Micrographic Surgery in Female Genital Cancers: A Systematic Review
November 2025 | Volume 24 | Issue 11 | Original Article | 1080 | Copyright © November 2025
Background: Mohs micrographic surgery (MMS) has shown promising efficacy in female genital cancers, including Extramammary Paget’s disease (EMPD), dermatofibrosarcoma protu...
Read MoreApremilast in the Treatment of Central Centrifugal Cicatricial Alopecia: An Open-Label Pilot Study
September 2025 | Volume 24 | Issue 9 | Original Article | 891 | Copyright © September 2025
Background: Central centrifugal cicatricial alopecia (CCCA) is a scarring alopecia primarily affecting Black women. To date, there are no standardized treatment regimens or appro...
Read MoreSquamous Cell Carcinoma In Situ on High-Risk Sites and With Larger Sizes Require More Stages for Clearance With Mohs Surgery
May 2025 | Volume 24 | Issue 5 | Original Article | 494 | Copyright © May 2025
Background: Few studies have evaluated Mohs micrographic surgery (MMS) for the treatment of squamous cell carcinoma in situ or evaluated the results by Mohs Appropriate Use Crite...
Read MoreHealing of Mohs Surgery Wounds on the Vermilion and Cutaneous Lip With Bovine Collagen Dressings
March 2025 | Volume 24 | Issue 3 | Original Article | 270 | Copyright © March 2025
Background: Surgical wounds confined to the vermilion lip and superficial orbicularis musculature can be allowed to heal by second intention with good aesthetic and functional re...
Read MoreInternational Dermatology Outcome Measures (IDEOM): A Report From the 2023 Annual Meeting
December 2024 | Volume 23 | Issue 12 | Original Article | 1114 | Copyright © December 2024
Background: International Dermatology Outcome Measures (IDEOM) is a non-profit organization whose mission is to improve the availability of evidence-based, consensus-driven outco...
Read MoreInternational Dermatology Outcome Measures (IDEOM): Report from the 2021 Annual Meeting
August 2022 | Volume 21 | Issue 8 | Original Article | 867 | Copyright © August 2022
Background: International Dermatology Outcome Measures (IDEOM) is a non-profit organization founded in 2013. It is composed of researchers and stakeholders who work to develop evidenc...
Read More© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
